FastSaying
The initial results of this phase I/II study in RA are very encouraging. We are looking forward to the ongoing development of HuMax-CD20 in RA.
Dr Lisa Drakeman
Study
Related Quotes
The initial results of this Phase I/II study in RA are very encouraging. We are looking forward to the ongoing development of HuMax-CD20 in RA.
— Lisa N. Drakeman
Study
If you look at divorce as a process in that you study the differences before, during and after divorce, it turns out the most harmful effects happen before the divorce even occurs.
— Lisa Strohschein
Divorce
Study
The effects that we saw over the initial six-month study seem to be maintained over one year.
— Dr. Barry Reisberg
Study
This was an important study to do. What it points out, apart from the negative results, is the importance of doing such randomized trials so that we know whether a particular treatment is effective or not.
— Dr. Andreas Wielgosz
Study
What this study does is beg some important questions.
— Dr. Farr Curlin
Study